Similar articles for PMID: 32727761

Year	Number of Results
1997	1
1999	1
2002	2
2003	1
2004	1
2005	1
2006	1
2007	2
2008	2
2009	8
2010	10
2011	7
2012	12
2013	14
2014	10
2015	12
2016	17
2017	14
2018	15
2019	11
2020	24
2021	20
2022	15
2023	13
2024	11
2025	1

1

Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.

Keikes L, Koopman M, Lemmens VEPP, VAN Oijen MGH, Punt CJA. Keikes L, et al. Anticancer Res. 2020 Aug;40(8):4331-4341. doi: 10.21873/anticanres.14436. Anticancer Res. 2020. PMID: 32727761

2

Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months.

Franken IA, van der Baan FH, Vink GR, May AM, van Grevenstein WMU, Koopman M, Roodhart JML. Franken IA, et al. Eur J Cancer. 2024 Sep;208:114207. doi: 10.1016/j.ejca.2024.114207. Epub 2024 Jul 10. Eur J Cancer. 2024. PMID: 39024724 Free article.

3

Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.

Verhoeff SR, van Erning FN, Lemmens VE, de Wilt JH, Pruijt JF. Verhoeff SR, et al. Int J Cancer. 2016 Jul 1;139(1):187-93. doi: 10.1002/ijc.30053. Epub 2016 Mar 12. Int J Cancer. 2016. PMID: 26914273

4

Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.

Babaei M, Balavarca Y, Jansen L, Lemmens V, van Erning FN, van Eycken L, Vaes E, Sjövall A, Glimelius B, Ulrich CM, Schrotz-King P, Brenner H. Babaei M, et al. Int J Cancer. 2018 Apr 1;142(7):1480-1489. doi: 10.1002/ijc.31168. Epub 2017 Dec 4. Int J Cancer. 2018. PMID: 29159866 Free PMC article.

5

Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.

van Gils CW, Koopman M, Mol L, Redekop WK, Uyl-de Groot CA, Punt CJ. van Gils CW, et al. Acta Oncol. 2012 Jan;51(1):57-64. doi: 10.3109/0284186X.2011.633930. Epub 2011 Nov 28. Acta Oncol. 2012. PMID: 22122695

6

Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands.

van Steenbergen LN, Rutten HJT, Creemers GJ, Pruijt JFM, Coebergh JWW, Lemmens VEPP. van Steenbergen LN, et al. Ann Oncol. 2010 Jun;21(6):1273-1278. doi: 10.1093/annonc/mdp482. Epub 2009 Oct 30. Ann Oncol. 2010. PMID: 19880434 Free article.

7

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.

André T, de Gramont A, Vernerey D, Chibaudel B, Bonnetain F, Tijeras-Raballand A, Scriva A, Hickish T, Tabernero J, Van Laethem JL, Banzi M, Maartense E, Shmueli E, Carlsson GU, Scheithauer W, Papamichael D, Möehler M, Landolfi S, Demetter P, Colote S, Tournigand C, Louvet C, Duval A, Fléjou JF, de Gramont A. André T, et al. J Clin Oncol. 2015 Dec 10;33(35):4176-87. doi: 10.1200/JCO.2015.63.4238. Epub 2015 Nov 2. J Clin Oncol. 2015. PMID: 26527776 Clinical Trial.

8

Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy.

Zaanan A, Fléjou JF, Emile JF, Des GG, Cuilliere-Dartigues P, Malka D, Lecaille C, Validire P, Louvet C, Rougier P, de Gramont A, Bonnetain F, Praz F, Taïeb J. Zaanan A, et al. Clin Cancer Res. 2011 Dec 1;17(23):7470-8. doi: 10.1158/1078-0432.CCR-11-1048. Epub 2011 Oct 13. Clin Cancer Res. 2011. PMID: 21998335

9

A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer.

Öhrling K, Karlberg M, Edler D, Hallström M, Ragnhammar P. Öhrling K, et al. Clin Colorectal Cancer. 2013 Jun;12(2):128-35. doi: 10.1016/j.clcc.2012.11.003. Epub 2012 Dec 29. Clin Colorectal Cancer. 2013. PMID: 23276521

10

Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.

Zhao H, Zhang N, Ho V, Ding M, He W, Niu J, Yang M, Du XL, Zorzi D, Chavez-MacGregor M, Giordano SH. Zhao H, et al. Cancer. 2018 Feb 15;124(4):679-687. doi: 10.1002/cncr.31094. Epub 2017 Nov 15. Cancer. 2018. PMID: 29140558 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 32727761

199 results

Results by year